UNSPSC 51285319: Nifuratel

This classification denotes an antifungal agents and antitrichomonal agents and antiprotozoal, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier U60U6P08SP. European Medicines Agency schedules Nifuratel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09261MIG. Nifuratel generally arises in the molecular formula C10H11N3O5S.

The term NIFURATEL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 21 no. 12 1967, list 7.) NIFURATEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51285319 Nifuratel, a Commodity code, does not reflect the actual scope of recent state and local solicitations tagged under it. The four posted opportunities span naloxone and drug deactivation systems, direct-to-manufacturer pharmaceutical programs, fire-rescue medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — none of which centers on nifuratel, a specific antiprotozoal pharmaceutical. State and local buyers are using this code to solicit broad pharmaceutical procurement, but the code's nominal specificity to a single drug does not align with the diverse product categories being purchased through these solicitations.

The issuing-body mix includes county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance with participation from Oregon and other states). Geographic activity spans Florida, Texas, Minnesota, and Oregon, with the cooperative purchasing vehicle extending reach across multiple state and local partners. Representative recent opportunities include Seminole County's IFB 60459723LAS (due July 26, 2023, seeking 1,900 units of naloxone and 800 drug deactivation systems annually); the City of Tampa's IFB 26P00145 (due March 13, 2026, seeking 169 line items of medical and first aid supplies for the Fire Department with an estimated contract value of $700,000.00 and a Small Local Business Enterprise set-aside); the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (due March 26, 2026, for generic multi-source pharmaceuticals and OTC products); and the Texas HHS Commission's RFI HHS0017013 (due April 3, 2026, exploring direct-to-manufacturer prescription fulfillment capabilities). The source shows no recent activity that aligns nifuratel specifically with the code's stated scope.